|
Symptoms
|
Questions
|
|
Headaches, dizziness, tinnitus, blurred vision, epistaxis, chest discomfort, palpitations, nervousness, fatigue
|
Does patient check blood pressure at home? What numbers are they getting? What are the highest and lowest numbers? How often are their numbers super high?
|
|
Complications
|
Any symptoms of HTN?
|
|
HF, CAD, MI, A Fib, aortic dissection, PAD, atherosclerosis, stroke, CKD, hypertensive nephrosclerosis, retinopathy
|
What medication(s) is the patient taking? Dose? How many times a day? How many days per week does the patient forget/does not have time to take their medication?
|
|
Risk Factors
|
|
|
Obesity, diabetes, smoking, excessive alcohol/caffeine, high sodium diet, physical inactivity, stress
|
|
|
Labs
|
|
|
CBC, creatinine, eGFR, BMP
|
|
|
ACEIs (lisinopril, enalapril)
|
Thiazide diuretics (HCTZ)
|
|
First-line for patients with DM, renal disease, ischaemic heart disease, and HF
|
Side effects: hypokalaemia, hyponatraemia, increased glucose and cholesterol
|
|
Side effects: dry cough, hyperkalaemia
|
___
|
|
Adverse effects: angioedema - STOP IMMEDIATELY
|
___
|
|
ARBs (losartan, valsartan)
|
Dihydropyridine CCB (amlodipine, nifedipine)
|
|
First-line for patients with DM, renal disease, ischaemic heart disease, and HF
|
Avoid in patients with HFrEF
|
|
Side effects: hyperkalaemia
|
Side effects: oedema, nausea, flushing, HA, GERD, gingival hyperplasia
|
|
Nondihydropyridine CCB (diltiazem, verapamil)
|
Beta blockers (propranolol, metoprolol)
|
|
Side effects: bradycardia, AV block, constipation, hyperprolactinaemia (verapamil)
|
Second-line therapy; used as primary drug in patients with HF, A Fib, ischaemic heart disease
|
|
Side effects: bronchoconstriction with non-cardioselective beta blockers, increased TG
|
|
Symptoms
|
Questions
|
|
Polyuria, polydipsia, polyphagia, vision changes, poor wound healing, numbness, tingling, constipation
|
Does pt check their blood sugars at home? When? What are their morning numbers (before eating)? Numbers during the day?
|
|
Labs
|
Highest and lowest blood sugars? How often? Any symptomatic low blood sugars?
|
|
A1c (every 3-6 months), BMP (renal function and electrolytes), LFTs, lipids, urine microalb/cr
|
If on insulin, how many units with which type of insulin? How often do they forget/are too busy to take their insulin?
|
|
Look For
|
Numbness, tingling, etc? Vision changes?
|
|
Statin therapy regardless, ASCVD assessment for high-intensity statin
|
Have they seen an eye doctor in the past year?
|
|
Last ophthalmology exam, podiatry
|
|
|
Physical Exam
|
|
|
Foot exam, acanthosis nigricans
|
|
|
Metformin
|
Sulphonylureas
|
|
Enhances effect of insulin. Weight loss.
|
Glyburide, glimepiride, glipizide
|
|
Side effects: lactic acidosis, GI complaints (only when first starting, D/C), decreased B12 absorption
|
Increase insulin secretion
|
|
Contraindication: CKD w/ GFR <30
|
Side effects: risk of hypoglycaemia, weight gain, agranulocytosis, haemolysis
|
|
_____
|
Contraindications: CV comorbidity, obesity, severe renal/liver failure
|
|
SGLT-2 Inhibitors
|
Meglitinides
|
|
Canagliflozin, dapagliflozin, empagliflozin
|
Nateglinide, repaglinide
|
|
Increases glucose excretion with urine
|
Increases insulin secretion
|
|
Side effects: genital yeast infections and UTI, polyuria and dehydration, DKAContraindication: CKD, recurrent UTIs
|
Side effects: risk of hypoglycaemia, weight gain
|
|
Contraindication: CKD, recurrent UTIs
|
Contraindication: severe liver failure
|
|
DPP-4 Inhibitors
|
GLP-1 Agonists
|
|
Saxagliptin, sitagliptin
|
Exenatide, liraglutide
|
|
Inhibits GLP-1 degradation
|
Stimulates GLP-1 receptors
|
|
Side effects: GI sx, pancreatitis, URI, headache, dizziness, oedema
|
Side effects: pancreatitis, possible pancreatic cancer, nausea
|
|
Contraindication: liver failure, moderate to severe renal failure
|
Contraindications: pre-existing, sx GI motility disorders
|
|
_____
|
______
|
|
_____
|
______
|
|
Rapid Acting Insulin
|
Long-Acting Insulin
|
|
Lispro, aspart, glulisine
|
Glargine, detemir, degludec
|
|
Onset: 5-15 min, Peak: 1 hr, Duration: 3-4 hrs
|
Onset: 1-4 hrs, Duration: 24 hrs
|
|
Before meals
|
Once daily
|
|
Adverse Effects of Insulin
|
|
|
Hypoglycaemia, weight gain, lipodystrophy, hypokalaemia, oedema, pain/erythema at injection site
|
|
|
Symptoms
|
Questions
|
|
Angina: Retrosternal chest pain/pressure that may radiate to the L arm, neck, jaw, or back. Pain is not affected by body position or breathing. No chest wall tenderness. Dyspnea, dizziness, palpitations, diaphoresis, n/v, syncope
|
Has patient had chest pain since last visit? Is it occuring more often or stable? Does nitro help relieve pain?
|
|
Stable angina: chest pain/sx reproducible/predictable, subside with rest or nitroglycerin.
|
Any hospitalisations since last visit?
|
|
Things to Check For
|
Medication compliance?
|
|
ASCVD score, new ECGs, stress tests, ECHO, CT angio, coronary artery calcium (CAC) scoring, cardiac catheterisations
|
Any of the other symptoms besides chest pain?
|
|
Revascularisation - PCI or CABG
|
If they follow with cardiology, when was the last time they were seen?
|
|
Secondary Prevention
|
|
|
Smoking cessation, increased physical activity, lifelonf antiplatelet therapy with aspiring or clopidogrel, treat comorbidities, lipid-lowering therapy
|
|
|
Anti-anginal Drugs
|
Antiplatelet Agents
|
|
First-line: beta-blockers
|
Recommended for all patients
|
|
Second-line: CCBs, nitrates, ranolazine
|
Aspirin, clopidogrel
|
|
ACEIs or ARBs
|
Revascularisation
|
|
In patients who also have HTN, DM, LVEF 40% or <, CKD
|
CABG
|
|
Lisinopril, ramipril. Losartan, valsartan.
|
PCI
|
|
Symptoms
|
Complications
|
|
Cough, dyspnea, fatigue, hyperventilation
|
Chronic respiratory failure, R HF (cor pulmonale), secondary spontaneous pneumothorax
|
|
Physical Exam
|
Treatment
|
|
Accessory muscle use, barrel chest, decreased breath sounds, end-expiratory wheezing and/or prolonged expiration, rhonchi/crackles, cyanosis, tachycardia, JVD, oedema, nail clubbing
|
Short-acting beta agonists: salbutamol
|
|
Labs
|
Long-acting beta agonists: salmeterol
|
|
CBC
|
Short-acting muscarinic antagonists: ipratropium bromide
|
|
Things To Look For
|
Long-acting muscarinic antagonists: tiotropium bromide
|
|
PFT: FEV1 and FEV1/FVC
|
Inhaled corticosteroids: budesonide, fluticasone
|
|
CXR, chest CT
|
|
|
Pulmonology clinic notes
|
|
|
Risk Factors
|
Treatment
|
|
DMII, HTN, obesity, advanced age, substance use, AKI
|
Diet
|
|
Aetiology
|
Avoidance of nephrotoxic substances: NSAIDs, antifungal, antibiotics, antivirals
|
|
Diabetic nephropathy, hypertensive nephropathy, glomerulonephritis, PKD, analgesic misuse, amyloidosis
|
Control underlying condition and comorbidities
|
|
Labs
|
Haemodialysis
|
|
CBC, BMP (Cr, BUN), PT, PTT, bleeding time, lipid panel, blood pH, eGFR, urinalysis, urine microalb/cr
|
Complications
|
|
CKD-mineral and bone disorder, secondary hyperparathyroidism, anaemia, ESRD
|
|
Symptoms
|
Lifestyle Modifications
|
|
Nocturia, fatigue, tachycardia, dyspnea, orthopnea, PND, peripheral oedema
|
Exercise, cessation of smoking/EtOH/recreational drugs, weight loss, immunisations
|
|
Physical Exam
|
Diet and fluid restriction
|
|
S3/S4 gallop, pulsus alternans, bilateral basilar crackles, displaced apical heart beat, peripheral pitting oedema, JVD, hepatojugular reflux
|
Self-monitoring and symptom recognition (if pt gains > 4-5 lbs within 3 days -> fluid overloaded)
|
|
Labs
|
Drugs to Avoid
|
|
CBC, BMP, LFTs, lipid panel
|
Most antiarrhythmic drugs, CCB (except amlodipine), NSAIDs, thiazolidinediones
|
|
Know baseline BNP
|
|
|
Look For
|
|
|
Echo - ejection fraction, valvular dysfunction
|
|
|
CXR - cardiac silhouette, pulmonary congestion
|
|
|
ECG - LVH
|
|
|
Cardiac MRI, L heart cath/angio, R heart cath
|
|
|
ACEIs
|
Aldosterone Antagonists
|
|
Enalapril, lisinopril
|
Spironolactone, eplerenone
|
|
Every patient with HFrEF
|
Class II-IV and LVEF <35%
|
|
ARBs
|
Monitor for hyperkalaemia
|
|
Losartan, valsartan
|
Loop Diuretics and Thiazide Diuretics
|
|
Beta Blockers
|
Loop: furosemide, torsemide
|
|
Carvedilol, metoprolol
|
Thiazide: HCTZ, metolazone, chlorthalidone
|
|
Add once patient is stable on ACEI/ARB and no decompensated
|
To treat volume overload
|
|
Symptoms
|
Things to Look Out For
|
|
Often asymptomatic
|
Child-Pugh score and MELD score every 6 months along with labs
|
|
Fatigue, pruritus, yellowing of skin or eyes, n/v, increased abdomen size, gynecomastia, hypogonadism
|
HCC screening (q6 months)
|
|
Physical Exam
|
Complications
|
|
Jaundice, telangiectasia, caput medusae, palmar erythema, hepatomegaly, splenomegaly, ascites, asterixis
|
Portal HTN, ascites, spontaneous bacterial peritonitis, oesophageal variceal haemorrhage, coagulopathy, hepatic encephalopathy, hepatorenal syndrome, hepatopulmonary syndrome, HCC, portal vein thrombosis
|
|
Labs
|
Treatment
|
|
CBC, LFTs, alk phos, ammonia, PT/INR, albumin
|
Treat underlying condition, avoid hepatotoxic substances (EtOH, NSAIDs), routine vaccines
|
|
Imaging
|
Non-selective beta blockers (propranolol) to lower portal HTN and prevent variceal bleeding
|
|
US, CT scan
|
Spironolactone and furosemide for ascites and oedema
|
No comments yet.
Cheatography n. The art of mapping complex subjects into clear, instantly navigable reference guides.